Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Goey AKL"'
Autor:
Cindy H. Chau, Kirk R. Gustafson, Shaunna L. Beedie, Emily M Harris, Phoebe A. Huang, Christopher J. Schofield, William D. Figg, Melissa M. Cadelis, Brent R. Copp, Jonathan D. Strope, Goey Akl, Kristina M. Cook
Publikováno v:
Marine Drugs
Volume 16
Issue 7
Marine Drugs, Vol 16, Iss 7, p 241 (2018)
Volume 16
Issue 7
Marine Drugs, Vol 16, Iss 7, p 241 (2018)
Elements of the hypoxia inducible factor (HIF) transcriptional system, a key regulator of the cellular hypoxic response, are up-regulated in a range of cancer cells. HIF is fundamentally involved in tumor angiogenesis, invasion, and energy metabolism
Autor:
Oturkar CC; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Rosario SR; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Hutson AD; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Groman A; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Edge SB; Department of Breast Surgery, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Morrison CD; Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Swetzig WM; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Wang J; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Park JH; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA., Kaipparettu BA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA., Singh PK; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Kumar S; Department of Breast Surgery, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Cappuccino HH; Department of Breast Surgery, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Ranjan M; Division of Breast Surgery, Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA., Adjei A; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Ghasemi M; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Goey AKL; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Kulkarni S; Division of Breast Surgery, Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA., Das GM; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Publikováno v:
IScience [iScience] 2024 May 15; Vol. 27 (6), pp. 109995. Date of Electronic Publication: 2024 May 15 (Print Publication: 2024).
Autor:
Boland PM; Department of Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Ebos JML; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Attwood K; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Mastri M; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Fountzilas C; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Iyer RV; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Banker C; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Goey AKL; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Bies R; Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, NY, USA., Ma WW; Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Fakih M; Department of Medicine, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
Publikováno v:
JNCI cancer spectrum [JNCI Cancer Spectr] 2024 Apr 30; Vol. 8 (3).
Autor:
Seon BK; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. Electronic address: ben.seon@roswellpark.org., Okazaki M; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Duzen J; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Matsuno F; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Goey AKL; Bioanalytics, Metabolomics and Pharmacokinetics (BMPK) Shared Resource, and Department of Pharmacology and Therapeutics, Rpswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Maguire O; Flow and Image Cytometry Shared Resource, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Publikováno v:
Leukemia research [Leuk Res] 2024 Jan; Vol. 136, pp. 107436. Date of Electronic Publication: 2024 Jan 09.
Autor:
Myszkiewicz MF; Bioanalytics, Metabolomics, and Pharmacokinetics Shared Resource, Roswell Park Comprehensive Cancer Center, Elm and Carlton Streets, Buffalo, NY 14263, USA., Puzanov I; Department of Medicine, Roswell Park Comprehensive Cancer Center, Elm and Carlton Streets, Buffalo, NY 14263, USA., Goey AKL; Bioanalytics, Metabolomics, and Pharmacokinetics Shared Resource, Roswell Park Comprehensive Cancer Center, Elm and Carlton Streets, Buffalo, NY 14263, USA; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Elm and Carlton Streets, Buffalo, NY 14263, USA. Electronic address: andrew.goey@roswellpark.org.
Publikováno v:
Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2023 Sep 20; Vol. 234, pp. 115594. Date of Electronic Publication: 2023 Jul 17.
Autor:
Lin LH; Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, NY, USA.; Bioanalytics, Metabolomics, and Pharmacokinetics Shared Resource, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Ghasemi M; Bioanalytics, Metabolomics, and Pharmacokinetics Shared Resource, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Burke SM; Bioanalytics, Metabolomics, and Pharmacokinetics Shared Resource, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Mavis CK; Department of Medicine-Lymphoma, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Nichols JR; Clinical Research Services, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Torka P; Department of Medicine-Lymphoma, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Mager DE; Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, NY, USA., Hernandez-Ilizaliturri FJ; Department of Medicine-Lymphoma, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Goey AKL; Bioanalytics, Metabolomics, and Pharmacokinetics Shared Resource, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. andrewgoey@gmail.com.; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. andrewgoey@gmail.com.
Publikováno v:
Targeted oncology [Target Oncol] 2023 Sep; Vol. 18 (5), pp. 685-695. Date of Electronic Publication: 2023 Aug 26.
Autor:
Burke SM; Bioanalytics, Metabolomics, and Pharmacokinetics Shared Resource, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Kamal M; Bioanalytics, Metabolomics, and Pharmacokinetics Shared Resource, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Goey AKL; Bioanalytics, Metabolomics, and Pharmacokinetics Shared Resource, Roswell Park Comprehensive Cancer Center, Buffalo, New York.; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
Publikováno v:
Therapeutic drug monitoring [Ther Drug Monit] 2023 Jun 01; Vol. 45 (3), pp. 327-336. Date of Electronic Publication: 2023 Jan 10.
Autor:
Mhandire DZ; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, 14263, USA., Goey AKL; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, 14263, USA. andrew.goey@roswellpark.org.
Publikováno v:
Molecular diagnosis & therapy [Mol Diagn Ther] 2022 Mar; Vol. 26 (2), pp. 137-151. Date of Electronic Publication: 2022 Feb 03.
Autor:
de Man FM; Department of Medical Oncology, Erasmus MC Cancer Institute, 's-Gravendijkwal 230, 3015, Rotterdam, The Netherlands., Goey AKL; Department of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, The Netherlands., van Schaik RHN; Department of Clinical Chemistry, Erasmus Medical Center, Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, 's-Gravendijkwal 230, 3015, Rotterdam, The Netherlands., Bins S; Department of Medical Oncology, Erasmus MC Cancer Institute, 's-Gravendijkwal 230, 3015, Rotterdam, The Netherlands. s.bins@erasmusmc.nl.
Publikováno v:
Clinical pharmacokinetics [Clin Pharmacokinet] 2018 Oct; Vol. 57 (10), pp. 1229-1254.
Autor:
Harris EM; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. emily.harris5050@gmail.com., Strope JD; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. jonathan.strope@nih.gov., Beedie SL; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. shaunna.beedie@oncology.ox.ac.uk., Huang PA; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. phoebe.huang@nih.gov., Goey AKL; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. andrewgoey@hotmail.com., Cook KM; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. kristina.cook@sydney.edu.au., Schofield CJ; Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Oxford OX1 5JJ, UK. christopher.schofield@chem.ox.ac.uk., Chau CH; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. chauc@mail.nih.gov., Cadelis MM; School of Chemical Sciences, University of Auckland, Auckland 1142, New Zealand. m.cadelis@auckland.ac.nz., Copp BR; School of Chemical Sciences, University of Auckland, Auckland 1142, New Zealand. b.copp@auckland.ac.nz., Gustafson KR; Molecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA. gustafki@mail.nih.gov., Figg WD; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. figgw@mail.nih.gov.
Publikováno v:
Marine drugs [Mar Drugs] 2018 Jul 19; Vol. 16 (7). Date of Electronic Publication: 2018 Jul 19.